ABX Advanced Biochemical Compounds GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:ABX Advanced Biochemical Compounds GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010857
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a biochemical compounds provider that manufactures, develops, and distributes biochemicals for nuclear medicine. The company’s products include PET and SPECT precursors and reference standards, reagents kits and cassettes, PET precursors and FDG reagents kits, custom synthesis, particularly kits, peptides, HCI, and radiotracers. It provides pharmaceutical kits and cassettes, APIs, ammpse triflate, precursors, glucose triflates, talose triflates, raclopride, tosyl fallypride, desmethoxyfallypride, fluoroethylspiperone, nitromazenil, flumazenil, harmol, harmine, and etomidate. The company also provides synthesis modules such as ORA NEPTIS mosaic-RS, SIEMENS Explora one, and ORA mosaic-LC and SCINTOMICS, among others. ABX is headquartered in Radeberg, Germany.

ABX Advanced Biochemical Compounds GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Endocyte Enters into Licensing Agreement with ABX 10
Equity Offering 11
Endocyte Raises Funds through Private Placement of Shares and Warrants 11
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 12
ABX Advanced Biochemical Compounds GmbH – Key Competitors 13
ABX Advanced Biochemical Compounds GmbH – Key Employees 14
ABX Advanced Biochemical Compounds GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Key Facts 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ABX Advanced Biochemical Compounds GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Endocyte Enters into Licensing Agreement with ABX 10
Endocyte Raises Funds through Private Placement of Shares and Warrants 11
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 12
ABX Advanced Biochemical Compounds GmbH, Key Competitors 13
ABX Advanced Biochemical Compounds GmbH, Key Employees 14

★海外企業調査レポート[ABX Advanced Biochemical Compounds GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析
    Summary Bioanalytical Systems Inc (Bioanalytical Systems) is a contract research organization. It provides drug discovery and development services, and analytical instruments. The company’s contract research services include screening and pharmacological testing, formulation development, preclinical …
  • Pine Cliff Energy Ltd (PNE):企業の財務・戦略的SWOT分析
    Summary Pine Cliff Energy Ltd (Pine Cliff) is an oil and gas company that offers exploration, production, and development of natural gas, crude oil, and natural gas liquids. The company operates through its core areas such as Edson Assets, Central Assets, and Southern Assets. It acquired Hatton prop …
  • Mega Uranium Ltd. (MGA):企業の財務・戦略的SWOT分析
    Mega Uranium Ltd. (MGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Commonwealth Scientific and Industrial Research Organisation:電力:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Daiichi Sankyo Co Ltd (4568):企業の財務・戦略的SWOT分析
    Daiichi Sankyo Co Ltd (4568) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Terumo Corporation:企業の戦略・SWOT・財務分析
    Terumo Corporation - Strategy, SWOT and Corporate Finance Report Summary Terumo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • VTB Bank:戦略・SWOT・企業財務分析
    VTB Bank - Strategy, SWOT and Corporate Finance Report Summary VTB Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • TDK Corporation:戦略・SWOT・企業財務分析
    TDK Corporation - Strategy, SWOT and Corporate Finance Report Summary TDK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BW Offshore Ltd (BWO):石油・ガス:M&Aディール及び事業提携情報
    Summary BW Offshore Ltd (BW Offshore) is a floating production services provider to the oil and gas industry. The company specializes in the design, development, and operation of oil and gas Floating Production, Storage and Offloading (FPSO) and Floating, Storage and Offloading (FSO) vessels. It off …
  • Halfords Group plc (HFD):企業の財務・戦略的SWOT分析
    Halfords Group plc (HFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Glanbia Nutritionals Inc:企業の戦略的SWOT分析
    Glanbia Nutritionals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Fortis Inc (FTS):企業の財務・戦略的SWOT分析
    Summary Fortis Inc (Fortis) is an oil and gas company that provides development of assets and market capitalization programs. The company offers measurement and monitoring of environmental impacts. It also provides capital program and growth plans to meet the energy needs. Fortis support and partici …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務情報
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • DermTech Inc:医療機器:M&Aディール及び事業提携情報
    Summary DermTech Inc (DermTech) is a dermatology company that develops non-invasive gene expression tests to facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The company’s products include adhesive skin sample collection kit, that allows co …
  • BSN medical GmbH:医療機器:M&Aディール及び事業提携情報
    Summary BSN medical GmbH (BSN medical), a subsidiary of Essity Aktiebolag, is healthcare company specialized in compression therapy, wound care and othropedics. It manufactures and markets medical products for wound care and related vascular diseases and lumphology, and non-invasive orthopedic produ …
  • Rex Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Rex Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Rex Energy Corp (Rex Energy) is an independent energy company. It carries out the acquisition, production, exploration and development of condensate, natural gas and natural gas liquids. It holds pro …
  • Carrabba’s Italian Grill, Inc.:企業の戦略・SWOT・財務情報
    Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report Summary Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AptarGroup Inc:企業の戦略・SWOT・財務分析
    AptarGroup Inc - Strategy, SWOT and Corporate Finance Report Summary AptarGroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Synopsys, Inc.:企業のM&A・事業提携・投資動向
    Synopsys, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Synopsys, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Hosken Consolidated Investments Ltd (HCI):企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆